NeuroPace (NPCE) Total Debt (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Total Debt of $59.0 million in Q1 2026, little changed quarter-over-quarter from $58.9 million in Q4 2025, and down 1.28% on a YoY basis from $59.8 million in Q1 2025.
NeuroPace (NPCE) Total Debt (2020 - 2026) Analysis & Trends
NeuroPace's Total Debt history runs 7 years deep, the most recent figure standing at $59.0 million for Q1 2026.
- In Q1 2026, Total Debt fell 1.28% year-over-year to $59.0 million; the TTM figure through Mar 2026 stood at $59.0 million (down 1.28% YoY), while the FY2025 annual figure was $58.9 million, down 1.08% from the prior year.
- Total Debt was $59.0 million for Q1 2026 at NeuroPace, roughly flat from $58.9 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $59.8 million in Q1 2025 to a low of $50.1 million in Q1 2022.
- Historically, Total Debt has averaged $56.4 million across 5 years, with a median of $58.0 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Total Debt declined 5.71% in 2022, then rose 7.76% in 2024.
- A 5-year view of Total Debt shows it stood at $52.9 million in 2022, then grew by 7.64% to $57.0 million in 2023, then grew by 4.51% to $59.5 million in 2024, then dropped by 1.08% to $58.9 million in 2025, then climbed by 0.23% to $59.0 million in 2026.
- The last three Total Debt figures came in at $59.0 million (Q1 2026), $58.9 million (Q4 2025), and $58.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 28.07 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.48 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.93 Bn |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn | 59.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.02 Mn |
| Dec 31, 2025 | 58.88 Mn |
| Sep 30, 2025 | 58.75 Mn |
| Jun 30, 2025 | 58.62 Mn |
| Mar 31, 2025 | 59.79 Mn |
| Dec 31, 2024 | 59.53 Mn |
| Sep 30, 2024 | 59.27 Mn |
| Jun 30, 2024 | 59.02 Mn |
| Mar 31, 2024 | 58.04 Mn |
| Dec 31, 2023 | 56.95 Mn |
| Sep 30, 2023 | 55.89 Mn |
| Jun 30, 2023 | 54.85 Mn |
| Mar 31, 2023 | 53.86 Mn |
| Dec 31, 2022 | 52.91 Mn |
| Sep 30, 2022 | 51.95 Mn |
| Jun 30, 2022 | 51.02 Mn |
| Mar 31, 2022 | 50.12 Mn |
| Dec 31, 2021 | 49.85 Mn |
| Sep 30, 2021 | 49.58 Mn |
| Jun 30, 2021 | 49.35 Mn |